Delivery Order SPE2DE21D0022-SPE2D625F23D3

Award Date 11/27/24
Potential Completion Date 12/27/24
Potential Value $1.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Summerfield, NC 27358, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0022
    Indefinite Delivery Contract
  • SPE2DE21D0022-SPE2D625F23D3
    Delivery Order

This is a federal contract award (SPE2DE21D0022|SPE2D625F23D3) from the Defense Logistics Agency (DLA) Troop Support Medical to Dove Medical Supply LLC, a minority-owned, woman-owned small disadvantaged business. The $1,355.72 fixed-price contract with economic price adjustment is for the delivery of positive control materials for flu, respiratory syncytial virus (RSV), and SARS-CoV-2 testing. The contract has an ultimate completion date of December 27, 2024 and was awarded on November 27, 2024.

Dove Medical Supply holds a $400 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract (SPE2DE21D0022) with the DLA Troop Support Medical, which was established through solicitation SPE2DE-17-R-0001. This five-year IDIQ contract, awarded on September 15, 2021, allows Dove Medical Supply to provide a comprehensive range of laboratory supplies to the Department of Defense and other federal customers. The current award is issued under this overarching IDIQ vehicle.

Generated 2/26/25, 9:57 AM